help button home button Endocrine Society JCEM JCEM Call for Nominations for EIC
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kern, P. A.
Right arrow Articles by Fournier, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kern, P. A.
Right arrow Articles by Fournier, M.
The Journal of Clinical Endocrinology & Metabolism Vol. 84, No. 11 4185-4190
Copyright © 1999 by The Endocrine Society


Original Studies

Effect of Weight Loss on Muscle Fiber Type, Fiber Size, Capillarity, and Succinate Dehydrogenase Activity in Humans1

Philip A. Kern, Rosa B. Simsolo2 and Mario Fournier

Department of Medicine, Division of Endocrinology, University of Arkansas for Medical Sciences, and The Central Arkansas Veterans Health Care System (P.A.K.), Little Rock, Arkansas 72205; and the Department of Medicine, Cedars-Sinai Medical Center, University of California School of Medicine (R.B.S., M.F.), Los Angeles, California 90048

Address all correspondence and requests for reprints to: Philip A. Kern, M.D., ACOS-Research, 151/LR, Central Arkansas Veterans Healthcare System, 4300 West 7th Street, Little Rock, Arkansas 72205. E-mail: kernphilipa{at}exchange.uams.edu


    Abstract
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
To examine the effects of weight loss on muscle oxidative properties, nine obese subjects (body mass index, 34 ± 1.5) had muscle biopsies before and after weight loss and weight stabilization. Weight loss ranged from 13–32 kg and represented 20.8 ± 2.1% of initial weight. After weight loss, there was no change in the proportions of oxidative (type I and type IIa) fibers and also no change in mean fiber cross-sectional area, whereas there was a small, but significant, decrease in the relative interstitial space (P < 0.05). However, weight loss resulted in a 32 ± 6% (mean ± SEM) increase in capillary/fiber ratio and a 54% increase in capillary density (P < 0.05). In addition, there was a 41 ± 13% increase in succinate dehydrogenase (SDH) activity (P < 0.05). This increase in muscle capillarization and SDH activity was seen in all fiber types, even the relatively lower oxidative type IIx fibers. There was a strong correlation between the change in capillary/fiber ratio and the change in SDH activity (r = 0.82; P < 0.02). Thus, weight loss resulted in no change in muscle fiber type or cross-sectional area, but produced increases in capillary/fiber ratio, capillary density, and SDH activity, suggesting an increase in muscle oxidative capacity.


    Introduction
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
OBESE SUBJECTS become insulin resistant, and this insulin resistance leads to type II diabetes mellitus in susceptible subjects (1). The public health implications of obesity-related insulin resistance are enormous because of the increasing incidence of both obesity and type 2 diabetes in the American population (2, 3). In all obese subjects, both diabetic and nondiabetic insulin sensitivity improves after weight loss (4, 5). However, the mechanism of obesity-related insulin resistance is unclear, as any changes in total body adiposity must ultimately lead to changes in glucose disposal.

Muscle is the primary tissue that controls glucose disposal (6), and previous studies have characterized many of the biochemical and histochemical features of muscle in insulin-sensitive and insulin-resistant subjects. Previous studies have observed that the capillary supply to muscle, expressed as the capillary/fiber ratio, was associated with insulin sensitivity (7, 8). In addition, the proportion of type I (red, oxidative) muscle fibers was associated with a higher level of insulin sensitivity, and conversely, insulin sensitivity was inversely related to the proportion of the glycolytic or low oxidative type IIb muscle fibers (8, 9, 10).

Obese subjects demonstrated a decreased proportion of type I muscle fibers, a corresponding increase in type IIb fibers, and an overall decrease in mitochondrial enzymes, suggesting a decrease in muscle oxidative capacity (8, 9, 11). In addition, several studies have demonstrated an inverse correlation between obesity or diabetes and capillary/fiber ratio (8, 12). Thus, these alterations in muscle in obese subjects may account for much of the insulin resistance of obesity. Insulin sensitivity is improved by exercise (13), and several studies have demonstrated parallel changes in biochemical and histochemical properties of muscle. An increase in capillary/fiber ratio following chronic exercise has been observed in several studies (14, 15). In addition, very intense endurance training led to an increase in the proportion of type I fibers along with a decrease in the proportion of low oxidative type IIb fibers (16).

Weight loss results in an improvement in insulin sensitivity, and hence, one would expect that weight loss would lead to changes in muscle that are associated with improved insulin sensitivity, such as an increase in capillary/fiber ratio and/or an increase in the proportion of type I muscle fibers. Although few studies have examined weight loss, one previous study examined seven subjects before and after a mean 16% weight loss and found no change in capillary/fiber ratio or fiber type, even though there was an increase in the glucose disposal rate (12).

This study examined the effects of weight loss and weight stabilization on muscle capillarization, fiber type, and succinate dehydrogenase (SDH), which is an indicator of muscle oxidative capacity. We found a consistent increase in capillary/fiber ratio and capillary density as well as an increase in muscle fiber SDH activity even though there was no change in the proportion of muscle fiber types.


    Subjects and Methods
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Subject recruitment

All subjects were recruited from the Cedars-Sinai Medical Center Weight Control Program. Characteristics of the subjects are shown in Table 1Go. All subjects had been weight stable at the initial weight for at least 3 months before beginning the study. The subjects were taking no medications; none of the subjects had diabetes, and no subject had a blood triglyceride level above 4.5 mmol/L. Exercise histories were taken on all subjects both before and after weight loss, and exercise was quantitated by estimating calories burned per week. After an overnight fast, a muscle biopsy was performed, and body composition was measured using bioelectric impedance. The weight loss program was comprised of weekly behavior modification classes, and the subjects consumed between 520–800 cal/day of a commercial dietary supplement (Health Management Resources, Boston, MA). All subjects were encouraged to lose as much weight as they could. When subjects had reached their goal weight, or stopped losing weight, a refeeding process was begun, with a goal of stabilizing the patient’s weight. After the patient had begun the refeeding process and maintained the reduced weight for at least 3 months, the second set of studies was performed. Thus, the muscle biopsy studies were performed at a steady state obese weight and at a steady state reduced obese weight.


View this table:
[in this window]
[in a new window]
 
Table 1. Characteristics of the subjects

 
Muscle sample preparation

Percutaneous biopsies of the vastus lateralis were performed at the midportion of the thigh (15 cm from patella) under local anesthesia using a needle biopsy technique (17, 18). Muscle samples (25–40 mg) were obtained from the same area of the thigh before and after the period of weight loss. The biopsy specimen was mounted on cork with embedding medium (OCT compound, Tissue-Tek, Miles Laboratories, Elkhart, IN), oriented for transverse sectioning (i.e. with fibers perpendicular to cork surface), and then rapidly frozen in isopentane, which had been cooled to its melting point by liquid nitrogen. The fresh-frozen muscle samples were stored at -80 C until analysis. For the assessment of muscle fiber classification, morphometry, capillarity, and quantitative enzyme measurements, serial cross-sections of the muscle sample were cut using a cryostat (Reichert-Jung, model 2800E) kept at -20 C.

Fiber type proportions

Serial muscle cross-sections of 10 µm thickness were stained for myofibrillar adenosine triphosphatase (mATPase) after alkaline (pH 9.6), and acid (pH 4.3 and 4.55) preincubations (19). One additional serial section was fixed in 2% paraformaldehyde at pH 7.4 for 2 min at room temperature and then preincubated at pH 9.6, in a modification of a previously described method (20). These various staining procedures allow the classification of human muscle fibers into several types, i.e. types I, IIa, IIx, and IIc. For each muscle sample, fiber-type proportions were determined from an analysis of 200–650 fibers within the entire cross-section. The histochemically determined fiber type was also verified immunohistochemically, with 95% or more correspondence between the mATPase-based classification and the major isoform of myosin heavy chain (MyHC) expressed in single muscle fibers (see also below).

Immunohistochemical identification of MyHC isoforms

As described previously, human muscle fibers that stain histochemically as type IIb fibers actually express MyHC 2X, and there is no evidence that human muscle expresses MyHC 2B (21, 22). Various anti-MyHC monoclonal antibodies (MAb) were used for the indirect immunoperoxidase identification of MyHC isoforms within single fibers. Serial muscle cryosections (10 µm thickness) matching the mATPase stains were dried at room temperature, fixed in cold acetone for 5 min, washed with phosphate-buffered saline (PBS) for 5 min, and incubated in 5% goat serum for 15 min at room temperature. Sections were incubated for 1 h at room temperature in one the following MAbs: A4.951 (dilution in PBS, 1:500) reacting with human MyHC 1 (ß/slow), N2.261 (1:750) reacting with human MyHC 1 and 2A, and A4.74 (1:50) reacting with human fast MyHCs (i.e. 2A and 2X). These mouse Mabs (IgG1) were raised from hybridoma cell lines obtained from American Type Culture Collection (Manassas, VA). Sections were rinsed with PBS (three times, 10 min each time) and exposed to peroxidase-conjugated secondary antibody (horse antimouse IgG; 1:200) for 30 min at room temperature. Control sections were exposed to secondary antibodies only. Sections were rinsed with PBS (three times, 10 min each time), exposed to ABC (Vector Laboratories, Inc., Burlingame, CA) reagent for 20 min at room temperature, and rinsed in PBS. Visualization was obtained after diaminobenzidene reaction (10 min) and nickel amplification. Sections were washed for 5 min, dehydrated, cleared, and mounted with Permount.

Fiber cross-sectional areas and relative interstitial space

Muscle fiber cross-sectional area was determined quantitatively from microscopic images of digitized muscle sections, using a computer-based image processing system. The latter is composed of a Leitz Laborlux S (Leica Corp., Rockleigh, NJ) microscope, CCD video camera system (model VI-470, Optronics Engineering, Goleta, CA), high resolution Trinitron color video monitor (model PVM-1343MD, Sony Electronics, Park Ridge, NJ), 486 DX-50 MHz PC with a Targa+ imaging board (Truevision, Inc., Indianapolis, IN) and Mocha image analysis software (v 1.20; Jandel Corp., San Rafael, CA). A microscope stage micrometer was used to calibrate the imaging system for morphometry. The cross-sectional areas of 100–200 individual fibers (i.e. sampled from those used in the analysis of fiber proportions) were determined from the number of pixels within manually outlined fiber boundaries. The relative interstitial space was determined by subtracting the cumulative fiber area from the total muscle cross-sectional area. Thus, the interstitial space refers to all nonmuscle space, which includes blood vessels, nerve branches, matrix proteins collagen, etc. The relative interstitial space was expressed as a percentage of the total muscle area.

Fiber capillarization

An acidic (pH 4.0) mATPase reaction was used to visualize capillaries surrounding individual muscle fibers from 10-µm thick serial cross-sections (23, 24). This technique has been validated by our group against other commonly used methods (i.e. amylase-periodic acid-Schiff) (25) and alkaline phosphatase (24). This ATPase method identifies only the arterial end of the capillary bed by staining the capillary endothelium. Furthermore, the mATPase technique used in this study does not distinguish between perfused and nonperfused vessels. Several indexes of capillarity were determined: 1) the capillary to fiber ratio, i.e. the total number of capillaries divided by the total number of fibers within the muscle section; 2) the capillary density, defined as the number of capillaries per mm2 muscle area; and 3) the number of capillaries per fiber (and per fiber type), i.e. capillary contacts per fiber, or the number of capillaries surrounding each fiber.

Single fiber SDH activity

Fiber oxidative capacity was determined by quantifying the activity of SDH (a key mitochondrial enzyme in the Krebs cycle) in individual muscle fibers. The methodology employed to quantitate SDH activity has been described in detail in previous reports (26, 27). Briefly, in the histochemical reaction for SDH, the progressive reduction of nitro blue tetrazolium (NBT) to an insoluble colored compound (a diformazan) is used as a reaction indicator. The reduction of NBT is mediated by H+ ions released in the conversion of succinate to fumarate. In a series of 6-µm thick sections, the incubation medium contained a large quantity of succinate (60 mM), and thus, the SDH reaction was not substrate limited. In other sections, succinate was absent from the incubation medium, so that the reduction of NBT in these sections was nonspecific. These sections are referred to as tissue blanks.

The concentration of NBT diformazan (NBT-dfz) deposited within a muscle fiber was calculated using the Beer Lambert equation: [NBT - dfz] = OD/(k x L), where OD was the optical density of the muscle fiber measured at 570 nm (the peak absorbance wave length for NBT-dfz), k was the molar extinction coefficient for NBT-dfz (26, 478 mol/cm), and L was the path length (i.e. 6-µm section thickness) for light absorbance. The OD of muscle fibers was determined using a microdensitometric procedure implemented on the computer-based image processing system. The video image was then digitized (8-bit gray level resolution) into a matrix of 1024 x 1024 pixels (picture elements). The gray levels of the video scanner were calibrated for photometry (OD units), using a series of neutral density filters (0.004–2.00 OD units; Melles Griot, Irvine, CA). During the SDH reaction, the formation of NBT-dfz in muscle fibers increased linearly over a period of at least 7–9 min. In reactions where succinate was absent from the reaction medium, there was measurable staining (i.e. reduction of NBT), but the OD did not change significantly across the same time periods. The tissue blank OD also corresponded to the OD measured at time zero in reactions where succinate was present in the medium. Based on these data, we justified the use of a single end-point measurement of OD, with a reaction time of 5 min. The reaction was stopped at 5 min by immediately rinsing sections (both tissue blanks and those with succinate) with distilled water. Sections were dried, mounted, and kept in the dark until images were scanned and digitized (~2–3 h). In previous experiments, we have determined that there were no significant changes in individual muscle fiber OD values if sections were scanned/digitized within 10 h after the end of the SDH reaction.

From these end-point measurements, a rate of SDH reaction was interpolated. The mean SDH activity of individual muscle fibers was determined by averaging the OD of all pixels within outlined muscle fibers. To correct for the nonspecific formation of NBT-dfz, the tissue blank OD for each fiber was subtracted from the OD measured when substrate was added to the incubation medium. From the Beer-Lambert equation, the mean SDH activity of each fiber was expressed as mmol fumarate per L tissue/min. Approximately 100–200 fibers (i.e. same fibers sampled for the measurement of cross-sectional area) were analyzed for SDH from each specimen. The SDH activity of each individual fiber was used to determine the mean SDH activity for each fiber type. Based on the relative contribution of different types of fibers to total muscle cross-sectional area, the mean total SDH activity was also determined for each muscle sample.

Statistics

All data were expressed as the mean ± SEM. Before and after weight loss data were analyzed nonparametrically using the Wilcoxon sign-rank test, and linear regressions used Pearson product-moment correlations.


    Results
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
Table 1Go shows the characteristics of the subjects before and after undergoing weight loss. The initial body mass index (BMI) ranged from 28.0–41.3, and subjects lost 19.9 ± 2.3 kg, which represented 20.8 ± 2.1% of the initial body weight. Subjects had muscle biopsies from the vastus lateralis before the weight loss and 3 months after weight stabilization and resumption of an eucaloric diet.

Fiber types, cross-sectional areas, and relative interstitial space

From the muscle biopsy specimens, muscle fibers were identified histochemically and immunohistochemically and were classified as type I, type IIa, or type IIx. Figure 1Go is a representative series of adjacent sections demonstrating the identification of muscle fiber type using both the histochemical and the immunohistochemical methods. As shown in Fig. 1Go, identical results were obtained with the identification of fibers as type I, type IIa, and type IIx. Using both methods to identify muscle fiber type proportions, muscle fiber typing was performed in each patient both before and after weight loss. As shown in Fig. 2AGo, there was no change in the proportions of the fiber types after weight loss. The mean percentage of type I fiber in the subjects was 45.8 ± 2.8% when obese and 46.4 ± 2.2% when reduced obese. In addition, there was no change in mean muscle fiber cross-sectional areas for each type of fiber before and after weight loss (Fig. 2BGo). Taking into account the fiber proportions and cross-sectional area of fibers, we estimated the relative contribution of specific fiber types to total muscle area and found it to be unchanged after weight loss (data not shown). However, assessment of the relative proportions of interstitial space and muscle area revealed that, after weight loss, the cumulative muscle fiber area increased, whereas the relative interstitial space decreased significantly from 8.6 ± 0.3% to 7.4 ± 0.3% (P < 0.05).



View larger version (116K):
[in this window]
[in a new window]
 
Figure 1. Photomicrograph of serial cryostat sections of the vastus lateralis stained for myosin ATPase with preincubation at pH 4.3 (A), pH 4.55 (B), and pH 9.6 (C) with prior paraformaldehyde fixation. Correspondence in fiber type classification by immunohistochemical methods is shown in additional sections, which were reacted with antibodies against MyHC 1 (D), MyHC 1 and 2A (E), and MyHC 2A and 2X (F) isoforms. I, A, and X, Type I, IIa, and IIx fibers, respectively. Calibration bar, 50 µm.

 


View larger version (29K):
[in this window]
[in a new window]
 
Figure 2. Effect of weight loss on muscle fiber type and muscle fiber cross-sectional area. A, Muscle fiber type before and after weight loss. B, Muscle fiber cross-sectional area (square microns) before and after weight loss.

 
Muscle fiber capillarity

Muscle fiber capillarization was measured in these subjects before and after weight loss, and several indexes of capillarity are shown in Table 2Go. As shown in Fig. 3Go, there was a significant increase in capillary contacts per fiber with weight loss in all subjects and in relation to all fiber types. As shown in Table 2Go, the mean number of capillaries contacting individual muscle fibers was increased, and this was also observed in each individual fiber type. The number of capillaries around types I, IIa, and IIx in the vastus lateralis increased significantly by 13%, 10%, and 5%, respectively, after weight loss (P < 0.05 for each). The capillary/fiber ratio, the capillary density, and the mean number of capillary contacts per fiber increased significantly by 32%, 54%, and 10%, respectively, in the vastus lateralis after the period of weight loss (P < 0.05). Together, these data are consistent with an overall increase in the number of capillaries in vastus lateralis after weight loss.


View this table:
[in this window]
[in a new window]
 
Table 2. Indexes of muscle capillarization

 


View larger version (23K):
[in this window]
[in a new window]
 
Figure 3. Effect of weight loss on capillary contacts per fiber in each fiber type. With each fiber type, this increase in capillary contacts per fiber was statistically significant (P < 0.02).

 
Muscle fiber oxidative capacities

Muscle oxidative capacity was assessed by measuring the rate of SDH activity within individual muscle fibers. As shown in Fig. 4Go, weight loss resulted in an increase in SDH activity that occurred in the most oxidative type I fibers (41%) as well in type IIa (36%) and IIx (33%) fibers (P < 0.05). Total SDH activity in the vastus lateralis was measured based on the mean SDH activity of each fiber type and the relative contribution of each specific type to the total muscle area (see above). Total SDH activity in the muscle samples was 1.51 ± 0.21 mmol fumarate/L tissue·min) in the obese subjects and 2.10 ± 0.29 in the reduced obese subjects (i.e. a 39% increase in SDH activity; P < 0.05). In addition, the increase in total SDH activity in the muscle samples correlated significantly with the change in capillary/fiber ratio (Fig. 5Go). Thus, subjects who demonstrated the largest increase in capillary/fiber ratio also demonstrated the largest increase in muscle SDH activity.



View larger version (29K):
[in this window]
[in a new window]
 
Figure 4. Effect of weight loss on muscle fiber SDH activity. SDH activity was determined in individual fibers for each of the fiber types indicated as described in Materials and Methods. SDH activity in all three fiber types was significantly increased after weight loss. *, P < 0.05.

 


View larger version (11K):
[in this window]
[in a new window]
 
Figure 5. Relationship between change in SDH activity and change in capillary/fiber ratio in each of the nine subjects. The change in total muscle SDH was significantly correlated with the change in capillary/fiber ratio.

 
The changes in capillary/fiber ratio and SDH could not be explained by a change in exercise habits. Some patients exercised moderately (~100 cal/day), whereas others did not exercise at all. Nevertheless, there was no significant correlation between the amount of exercise or the change in exercise habits and any metabolic property of muscle. Specifically, a change in exercise habits bore no correlation to change in capillary/fiber ratio, SDH activity, or fiber type.


    Discussion
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 
This study examined a number of important properties of muscle in obese subjects before and after weight loss. The subjects were at a new steady state at the time of the reduced obese study, were no longer hypocaloric, and had not lost any additional weight in at least 3 months. In addition, the subjects in this study were fairly representative of obese subjects who lose weight. The average BMI of the subjects was 33.8, and the most obese subject had a BMI of 41. Overall, these subjects lost 20% of their initial body weight.

Compared to the muscle biopsy samples from the obese state, the reduced obese muscle samples demonstrated the same proportion of type I, type IIa, and type IIx fibers. There was no change in the mean cross-sectional area of individual fibers for all three muscle fiber types, whereas there was a small, but significant, decrease in the relative interstitial space. As a greater area of the muscle was occupied by muscle fibers after weight loss, this could translate into an increase in muscle specific force (i.e. force produced per unit area). Although there was no change in fiber type, there was a consistent increase in the oxidative capacity of each muscle fiber type along with a consistent increase in the capillary/fiber ratio and capillary density. In addition, the changes in capillary/fiber ratio closely paralleled the changes in muscle SDH activity.

Weight loss is known to result in an improvement in insulin sensitivity (4, 5). Subjects that are more insulin sensitive tend to have an increased proportion of type I muscle fibers, a higher capillary/fiber ratio, and higher muscle oxidative enzyme activity (7, 8, 9, 10). Some studies have also demonstrated a relationship between fiber type and some measure of central adiposity (8, 10, 28, 29), suggesting that muscle fiber type is part of the metabolic syndrome characterized by central adiposity, insulin resistance, hypertension, and dyslipidemia (30). Although one would expect an increase in insulin sensitivity with the weight reduction reported herein, measurements of insulin sensitivity were not performed. Hence, this study cannot determine whether the changes in muscle capillarization were associated with changes in insulin sensitivity.

There are a number of possible explanations for the changes observed in these subjects. The prolonged period of weight loss that these subjects experienced is characterized by relative hypoinsulinemia, hyperglucagonemia, and elevated nonesterified fatty acids (NEFA), which are released by adipose tissue and are eventually metabolized by muscle. Any one of these circulating hormones or substrates may be a driving force to increase muscle oxidative capacity. As the oxidative capacity of muscle fibers represents their ability to metabolize NEFA, it is interesting to speculate that the chronically elevated NEFA represents a substrate-driven change in muscle oxidative capacity. However, relatively few studies have examined subjects before and after weight loss, and one should not assume that reduced obese subjects are metabolically identical to subjects who were never obese. In one study where reduced obese and lean women were compared, the reduced obese women demonstrated decreased levels of some oxidative enzymes (31).

Although weight loss resulted in changes in oxidative capacity and capillarization, there was no change in muscle fiber type. This discordance between change in fiber type and oxidative capacity is interesting and contrasts with the increase in type I fibers seen in lean subjects in cross-sectional studies (8, 9, 11). Fiber type is determined by the isoforms of myosin and their ATPase. Although prolonged and intense endurance training can result in an increase in the proportion of higher oxidative (type I and type IIa) muscle fibers (16), the proportion of muscle fiber types is largely under genetic control (32) and less subject to change. Because others have noted an association between muscle oxidative capacity and waist/hip ratio or other measures of abdominal adiposity (8, 10, 28, 29), it is interesting to speculate that a low oxidative capacity of muscle is part of the phenotype of the metabolic syndrome (syndrome X) (30).

It would be of interest to examine the effects of weight loss on other muscles in addition to the vastus lateralis. The vastus lateralis is the usual site chosen for studies of human muscle, mainly because of the ease of biopsy, but also because it is composed of a mix of both slow and fast fibers. In one study that related muscle oxidative capacity to insulin sensitivity, vastus lateralis muscle oxidative capacity correlated with insulin sensitivity, whereas no such changes occurred in gastrocnemius muscle (33). Thus, it appears that vastus lateralis is a good representative muscle for these studies.

In summary, we examined fiber type, fiber size, SDH, and capillarization of vastus lateralis muscle from obese subjects before and after weight loss. Weight loss resulted in increases in capillarization and oxidative capacity in all fiber types, but without a change in the proportions of the different fiber types and their individual cross-sectional areas. These studies provided new insight into the mechanisms underlying the insulin resistance of obesity.


    Acknowledgments
 
We acknowledge the technical assistance of John Ong, Ada Yukht, and Xiaoyu Da for technical assistance in the laboratory, and the staff of the General Clinical Research Center at Cedars-Sinai Medical Center.


    Footnotes
 
1 This work was supported by NIH Grant DK-39176, a Grant-in-Aid from the American Heart Association, a Merit Review grant from the V.A., and Grant RR-00425 from the General Clinical Research Program of the National Center for Research Resources of the NIH. This work was performed during the tenure of an Established Investigatorship from the American Heart Association (to P.A.K). Back

2 Current address: Cnel. Niceto Vega, 4871 2:6, 1414 Buenos Aires, Argentina. Back

Received March 4, 1999.

Revised May 24, 1999.

Accepted July 12, 1999.


    References
 Top
 Abstract
 Introduction
 Subjects and Methods
 Results
 Discussion
 References
 

  1. Ludvik B, Nolan JJ, Baloga J, Sacks D, Olefsky J. 1995 Effect of obesity on insulin resistance in normal subjects and patients with NIDDM. Diabetes. 44:1121–1125.[Abstract]
  2. Kuczmarski RJ, Flegal KM, Campbell SM, Johnson CL. 1994 Increasing prevalence of overweight among US adults: the National Health and Nutrition Examination Surveys, 1960 to 1991. JAMA. 272:205–211.[Abstract]
  3. Harris MI, Flegal KM, Cowie CC, et al. 1998 Prevalence of diabetes, impaired fasting glucose, and impaired glucose tolerance in U.S. adults. The Third National Health and Nutrition Examination Survey, 1988–1994. Diabetes Care. 21:518–524.[Abstract]
  4. Friedman JE, Dohm GL, Leggett-Frazier N, Elton CW, Tapscott EB, Pories WP, Caro JF. 1992 Restoration of insulin responsiveness in skeletal muscle of morbidly obese patients after weight loss. Effect on muscle glucose transport and glucose transporter GLUT4. J Clin Invest. 89:701–705.
  5. Henry RR, Gumbiner B. 1991 Benefits and limitations of very-low-calorie diet therapy in obese NIDDM. Diabetes Care. 14:802–823.[Abstract]
  6. DeFronzo RA, Jacot E, Jequier E, Maeder E, Wahren J, Felber JP. 1981 The effect of insulin on the disposal of intravenous glucose. Results from indirect calorimetry and hepatic and femoral venous catheterization. Diabetes. 30:1000–1007.[Medline]
  7. Lithell H, Lindgarde F, Hellsing K, Lundquist G, Nygarrd E, Vessby B, Saltin B. 1981 Body weight, skeletal muscle morphology and enzyme activities in relation to fasting serum insulin concentration and glucose tolerance in 48 year old men. Diabetes. 30:19–25.[Abstract]
  8. Lillioja S, Young AA, Culter CL, et al. 1987 Skeletal muscle capillary density and fiber type are possible determinants of in vivo insulin resistance in man. J Clin Invest. 80:415–424.
  9. Hickey MS, Carey JO, Azevedo JL, Houmard JA, Pories WJ, Israel RG, Dohm GL. 1995 Skeletal muscle fiber composition is related to adiposity and in vitro glucose transport rate in humans. Am J Physiol. 268::E453—E457.
  10. Marin P, Andersson B, Krotkiewski M, Bjorntorp P. 1994 Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care. 17:382–386.[Abstract]
  11. Kriketos AD, Pan DA, Lillioja S, et al. 1996 Interrelationships between muscle morphology, insulin action, and adiposity. Am J Physiol. 270: R1332—R1339.
  12. Niskanen L, Uusitupa M, Sarlund H, Siitonen O, Paljarvi L, Laakso M. 1996 The effects of weight loss on insulin sensitivity, skeletal muscle composition and capillary density in obese non-diabetic subjects. Int J Obes Related Metab Disord. 20:154–160.[Medline]
  13. Horton ES. 1986 Exercise and physical training: effects on insulin sensitivity and glucose metabolism. Diabetes Metab Rev. 2:1–44.[Medline]
  14. Krotkiewski M, Bylund-Fallenius A-C, Holm J, Bjorntorp P, Grimby G, Mandroukas K. 1983 Relationship between muscle morphology and metabolism in obese women: the effects of long-term physical training. Eur J Clin Invest. 13:5–12.[Medline]
  15. Ebeling P, Bourey R, Koranyi L, et al. 1993 Mechanism of enhanced insulin sensitivity in athletes. Increased blood flow, muscle glucose transport protein (GLUT-4) concentration, and glycogen synthase activity. J Clin Invest. 92:1623–1631.
  16. Andersen P, Henriksson J. 1977 Training induced changes in the subgroups of human type II skeletal muscle fibers. Acta Physiol Scand. 99:123–125.[Medline]
  17. Bergström J. 1962 Muscle electrolytes in man. Scand J Clin Lab Invest. 68:12–100.
  18. Simsolo RB, Ong JM, Kern PA. 1993 The regulation of adipose tissue and muscle lipoprotein lipase in runners by detraining. J Clin Invest. 92:2124–2130.
  19. Brooke MH, Kaiser KK. 1970 Muscle fiber types: how many and what kind? Arch Neurol. 23:369–379.[Medline]
  20. Guth L, Samaha FJ. 1970 Procedure for the histochemical demonstration of actomyosin ATPase. Exp Neurol. 28:365–367.[CrossRef][Medline]
  21. Smerdu V, Karsch-Mizrachi I, Campione M, Leinwand L, Schiaffino S. 1994 Type IIx myosin heavy chain transcripts are expressed in type IIb fibers of human skeletal muscle. Am J Physiol. 267:t-8.
  22. Ennion S, Sant’ana PJ, Sargeant AJ, Young A, Goldspink G. 1995 Characterization of human skeletal muscle fibres according to the myosin heavy chains they express. J Muscle Res Cell Motility. 16:35–43.[CrossRef][Medline]
  23. Enad JG, Fournier M, Sieck GC. 1989 Oxidative capacity and capillary density of diaphragm motor units. J Appl Physiol. 67:620–627.[Abstract/Free Full Text]
  24. Sillau AH, Banchero N. 1977 Visualization of capillaries in skeletal muscle by the ATPase reaction. Pflugers Arch Eur J Physiol. 369:269–271.[CrossRef][Medline]
  25. Sieck GC, Cheung TS, Blanco CE. 1991 Diaphragm capillarity and oxidative capacity during postnatal development. J Appl Physiol. 70:103–111.[Abstract/Free Full Text]
  26. Blanco CE, Fournier M, Sieck GC. 1991 Metabolic variability within individual fibres of the cat tibialis posterior and diaphragm muscles. Histochem J. 23:366–374.[CrossRef][Medline]
  27. Blanco CE, Sieck GC, Edgerton VR. 1988 Quantitative histochemical determination of succinic dehydrogenase activity in skeletal muscle fibres. Histochem J. 20:230–243.[CrossRef][Medline]
  28. Seidell JC, Björntorp P, Sjöström L, Sannerstedt R, Krotkiewski M, Kvist H. 1989 Regional distribution of muscle and fat mass in men–new insight into the risk of abdominal obesity using computed tomography. Int J Obes. 13:289–303.[Medline]
  29. Mårin P, Andersson B, Krotkiewski M, Björntorp P. 1994 Muscle fiber composition and capillary density in women and men with NIDDM. Diabetes Care. 17:382–386.
  30. Reaven GM. 1988 Role of insulin-resistance in human disease. Diabetes. 37:1595–1607.[Abstract]
  31. Raben A, Mygind E, Astrup A. 1998 Lower activity of oxidative key enzymes and smaller fiber areas in skeletal muscle of postobese women. Am J Physiol. 275:t-94.
  32. Saltin B, Gollnick PD. 1983 Skeletal muscle adaptability: significance for metabolism and performance. In: Peachey LD, Adrian RH, Geiger SR eds. Handbook of physiology, sect 10. Bethesda: American Physiological Society; 555–632.
  33. Hickey MS, Weidner MD, Gavigan KE, Zheng D, Tyndall GL, Houmard JA. 1995 The insulin action-fiber type relationship in humans is muscle group specific. Am J Physiol. 269: E150—E154.



This article has been cited by other articles:


Home page
DiabetesHome page
F. G.S. Toledo, E. V. Menshikova, K. Azuma, Z. Radikova, C. A. Kelley, V. B. Ritov, and D. E. Kelley
Mitochondrial Capacity in Skeletal Muscle Is Not Stimulated by Weight Loss Despite Increases in Insulin Action and Decreases in Intramyocellular Lipid Content
Diabetes, April 1, 2008; 57(4): 987 - 994.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
M. I. Lewis, M. Fournier, T. W. Storer, S. Bhasin, J. Porszasz, S.-G. Ren, X. Da, and R. Casaburi
Skeletal muscle adaptations to testosterone and resistance training in men with COPD
J Appl Physiol, October 1, 2007; 103(4): 1299 - 1310.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
A. Yao-Borengasser, V. Varma, A. M. Bodles, N. Rasouli, B. Phanavanh, M.-J. Lee, T. Starks, L. M. Kern, H. J. Spencer III, A. A. Rashidi, et al.
Retinol Binding Protein 4 Expression in Humans: Relationship to Insulin Resistance, Inflammation, and Response to Pioglitazone
J. Clin. Endocrinol. Metab., July 1, 2007; 92(7): 2590 - 2597.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
V. Varma, A. Yao-Borengasser, N. Rasouli, A. M. Bodles, B. Phanavanh, M.-J. Lee, T. Starks, L. M. Kern, H. J. Spencer III, R. E. McGehee Jr., et al.
Human Visfatin Expression: Relationship to Insulin Sensitivity, Intramyocellular Lipids, and Inflammation
J. Clin. Endocrinol. Metab., February 1, 2007; 92(2): 666 - 672.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
A. Yao-Borengasser, N. Rasouli, V. Varma, L. M. Miles, B. Phanavanh, T. N. Starks, J. Phan, H. J. Spencer III, R. E. McGehee Jr., K. Reue, et al.
Lipin Expression Is Attenuated in Adipose Tissue of Insulin-Resistant Human Subjects and Increases With Peroxisome Proliferator-Activated Receptor {gamma} Activation.
Diabetes, October 1, 2006; 55(10): 2811 - 2818.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. Lopez-Soriano, C. Chiellini, M. Maffei, P. A. Grimaldi, and J. M. Argiles
Roles of Skeletal Muscle and Peroxisome Proliferator-Activated Receptors in the Development and Treatment of Obesity
Endocr. Rev., May 1, 2006; 27(3): 318 - 329.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
N. Rasouli, U. Raue, L. M. Miles, T. Lu, G. B. Di Gregorio, S. C. Elbein, and P. A. Kern
Pioglitazone improves insulin sensitivity through reduction in muscle lipid and redistribution of lipid into adipose tissue
Am J Physiol Endocrinol Metab, May 1, 2005; 288(5): E930 - E934.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
E. V. Menshikova, V. B. Ritov, F. G. S. Toledo, R. E. Ferrell, B. H. Goodpaster, and D. E. Kelley
Effects of weight loss and physical activity on skeletal muscle mitochondrial function in obesity
Am J Physiol Endocrinol Metab, April 1, 2005; 288(4): E818 - E825.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
G. Perdomo, S. R. Commerford, A.-M. T. Richard, S. H. Adams, B. E. Corkey, R. M. O'Doherty, and N. F. Brown
Increased {beta}-Oxidation in Muscle Cells Enhances Insulin-stimulated Glucose Metabolism and Protects against Fatty Acid-induced Insulin Resistance Despite Intramyocellular Lipid Accumulation
J. Biol. Chem., June 25, 2004; 279(26): 27177 - 27186.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Rosenbaum, K. Vandenborne, R. Goldsmith, J.-A. Simoneau, S. Heymsfield, D. R. Joanisse, J. Hirsch, E. Murphy, D. Matthews, K. R. Segal, et al.
Effects of experimental weight perturbation on skeletal muscle work efficiency in human subjects
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2003; 285(1): R183 - R192.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kern, P. A.
Right arrow Articles by Fournier, M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kern, P. A.
Right arrow Articles by Fournier, M.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals